揭示了癌症中RNAm5C阅读器YBX1的免疫功能
Chunhong Li1, Yixiao Yuan2, Xiulin Jiang2
1Department of Oncology, Suining Central Hospital, Suining, Sichuan, China.
Frontiers in immunology
|December 5, 2025
概括
Y盒结合蛋白1 (YBX1) 通过调节基因表达和免疫微环境,驱动癌症的进展和治疗耐药性. 准YBX1为新型癌症治疗提供了一个有前途的战略.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 免疫学 免疫学 免疫学
背景情况:
- Y盒结合蛋白1 (YBX1) 是一种关键的RNA结合蛋白,涉及各种癌症.
- YBX1通过与非编码RNA和蛋白质稳定相互作用来影响瘤发生.
- YBX1还影响瘤的免疫微环境和免疫治疗反应.
研究的目的:
- 阐明YBX1在癌症进展中的多方面的作用.
- 研究YBX1在调节基因表达和蛋白质相互作用中的机制.
- 探索YBX1对瘤免疫微环境的影响及其治疗含义.
主要方法:
- 对YBX1与长非编码RNA (lncRNA) 和圆形RNA (circRNA) 的相互作用进行分析.
- 研究YBX1在蛋白质-蛋白质相互作用和核转位中的作用.
- 检查YBX1对m5C等RNA修饰的识别能力.
- 评估YBX1对免疫细胞活性和免疫疗法疗效的影响.
主要成果:
- YBX1通过lncRNA和circRNA相互作用调节基因转录和翻译.
- YBX1稳定瘤原因子,并促进它们的核转移.
- 通过m5C修饰识别,YBX1增强了mRNA稳定性和翻译.
- YBX1以m5C依赖和独立的方式调节免疫细胞活性和免疫疗法反应.
结论:
- YBX1是癌症进展和治疗耐药性的关键驱动因素.
- YBX1集成了表观转录学调节,RNA-蛋白相互作用和免疫调节.
- YBX1代表了组合癌症治疗的潜在生物标志物和治疗标.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Epigenetic Regulation
33.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.4K
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Induced Pluripotent Stem Cells
5.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.3K
Rous Sarcoma Virus (RSV) and Cancer
6.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.1K


